Duration: CME/CE Points: Author(s):
Contact Hours : 1

CARDIOTHORACIC ANESTHESIOLOGY: Albumin Is Predictive of 1-Year Mortality After Transcatheter Aortic Valve Replacement is organized by The Society of Thoracic Surgeons (STS).

Release Date: Nov 01, 2018
Expiry Date: Nov 01, 2020

Accreditation: 1.0 AMA PRA Category 1 Credit ™

Each STS CME activity in The Annals consists of a self-study test on an original article from one of the journal's major subject categories (Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Cardiothoracic Anesthesiology), a statement of the learning objectives and an evaluation of the activity.

Learning Objective:
After reading this article, the learner should be able to:
• identify the limitation of various risk prediction models after TAVR.
• recognize that the current risk prediction models used for TAVR were specifically developed for SAVR population.
• illustrate the subjective nature of various frailty assessment tools.
• identify the value of serum albumin as an objective and modifiable risk predictor.
• reconstruct TAVR specific 1-year risk prediction models with inclusion of serum albumin as a variable.

Target Audience

The intended audience consists of thoracic and cardiothoracic surgeons, pediatric cardiac surgeons, general surgeons, anesthesiologists, oncologists, cardiologists, pulmonologists, and radiologists. MDs and DOs can take the CME activities for credit; non-MDs and non-DOs should not claim credit.


Activity Fee : Fee Details will be updated soon



Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.